Megumi Murakami Selected Research

Megumi Murakami Research Topics

Disease

22	Neoplasms (Cancer) 01/2024 - 01/2017
2	Colonic Neoplasms (Colon Cancer) 04/2023 - 11/2021
2	Breast Neoplasms (Breast Cancer) 01/2023 - 11/2017
2	Stroke (Strokes) 10/2009 - 09/2006
1	Hematologic Neoplasms (Hematological Malignancy) 11/2023
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 04/2023
1	Colitis-Associated Neoplasms 04/2023
1	Ulcerative Colitis 04/2023
1	Crohn Disease (Crohn's Disease) 04/2023
1	Amyopathic dermatomyositis 01/2023
1	Dermatomyositis (Dermatopolymyositis) 01/2023
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 05/2022
1	Rheumatoid Arthritis 01/2019
1	Chronic Disease (Chronic Diseases) 01/2019
1	Chronic Pain 01/2019
1	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2019
1	Hepatocellular Carcinoma (Hepatoma) 01/2019
1	Stomach Neoplasms (Stomach Cancer) 10/2018
1	Lymphatic Metastasis 10/2018
1	Neoplasm Metastasis (Metastasis) 10/2018
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2017

Drug/Important Bio-Agent (IBA)

13	Adenosine Triphosphate (ATP)IBA 01/2024 - 01/2017
9	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 01/2024 - 11/2020
9	ATP-Binding Cassette Transporters (ABC Transporters)IBA 01/2024 - 11/2017
3	Proteins (Proteins, Gene)FDA Link 01/2023 - 11/2017
2	ErbB Receptors (EGF Receptor)IBA 01/2024 - 11/2017
2	Tyrosine Kinase InhibitorsIBA 09/2023 - 05/2022
2	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 01/2023 - 01/2017
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2024
1	mobocertinibIBA 01/2024
1	CoumarinsIBA 11/2023
1	imperatorinIBA 11/2023
1	aflutinibIBA 09/2023
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 04/2023
1	sodium sulfate (sodium bisulfate)FDA LinkGeneric 04/2023
1	chymase 2IBA 04/2023
1	Infliximab (Remicade)FDA Link 04/2023
1	AntibodiesIBA 04/2023
1	AzoxymethaneIBA 04/2023
1	Chymases (Chymase)IBA 04/2023
1	Dextrans (Dextran)FDA Link 04/2023
1	Peptide Hydrolases (Proteases)FDA Link 04/2023
1	ethyl 6- (5- (phenylsulfonamido)pyridin- 3- yl)imidazo(1,2- a)pyridine- 3- carboxylateIBA 01/2023
1	pembrolizumabIBA 01/2023
1	hydroxygenkwaninIBA 10/2022
1	Adenosine Triphosphatases (ATPase)IBA 10/2022
1	Drug CombinationsIBA 10/2022
1	Anaplastic Lymphoma KinaseIBA 05/2022
1	ensartinibIBA 05/2022
1	Antineoplastic Agents (Antineoplastics)IBA 05/2022
1	N- methyl- 4- (4- (3- (trifluoromethyl)benzamido)phenoxy)picolinamideIBA 05/2022
1	TAK-243IBA 01/2022
1	Irinotecan (Camptosar)FDA LinkGeneric 11/2021
1	Member 2 Subfamily G ATP Binding Cassette TransporterIBA 11/2021
1	branebrutinibIBA 01/2021
1	Agammaglobulinaemia Tyrosine KinaseIBA 01/2021
1	Purinergic P1 Receptor AgonistsIBA 01/2019
1	Prostaglandins AIBA 10/2018
1	ricolinostatIBA 01/2018
1	AlkaloidsIBA 01/2018
1	Histone Deacetylase 6IBA 01/2018
1	TyrphostinsIBA 11/2017
1	pheophorbide aIBA 11/2017
1	CurcuminIBA 11/2017
1	Mitoxantrone (Novantrone)FDA LinkGeneric 11/2017
1	mangostinIBA 01/2017
1	TOR Serine-Threonine KinasesIBA 01/2017
1	PF-4989216IBA 01/2017
1	Phosphatidylinositols (Phosphatidylinositol)IBA 01/2017
1	Phosphotransferases (Kinase)IBA 01/2017
1	xanthoneIBA 01/2017
1	Blood Glucose (Blood Sugar)IBA 10/2009
1	Peptides (Polypeptides)IBA 10/2009
1	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 10/2009
1	Glucose (Dextrose)FDA LinkGeneric 10/2009
1	Antihypertensive Agents (Antihypertensives)IBA 09/2006
1	SaltsIBA 09/2006

Therapy/Procedure

10	Therapeutics 01/2024 - 09/2006
10	Drug Therapy (Chemotherapy) 01/2024 - 01/2017
1	Combination Drug Therapy (Combination Chemotherapy) 11/2023